ArticleACS omega2025
First Step into Praziquantel Raw Material Color Change Investigation: The Role of Thermal, Spectroscopic, and Microscopic Techniques.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Praziquantel (PZQ) is an anthelmintic agent used worldwide for the treatment of schistosomiasis. PZQ is used as a racemate, and it is practically insoluble in water. The PZQ racemate is a white to nearly white crystalline powder, and few studies showed a color change from white to pink. However, no special attention has been given to this matter. The present study aimed at a comprehensive understanding of PZQ change in color because a significant impact on its dissolution was observed. We discuss a series of analytical techniques, and we emphasize the importance of understanding solid state properties together with the conventional quality control evaluation. Two batches of PZQ raw material with different colors (white and light pink) were used. The dissolution profiles of the samples and the wettability were significantly different, and in addition, the pink color sample, when it came into contact with an acid medium, turned white. Because of these results, the presence of another phase in the pink sample was investigated and confirmed by powder X-ray diffraction. We were able to isolate the unknown phase for the first time, and with the characterization using Raman, infrared, and nuclear magnetic resonance, we proved that the pink color was related to an impurity with low crystallinity. It was observed through microscopy that this impurity with low crystallinity after the contact with the acid medium crystallizes, causing the pink color to turn white. Also, we showed that depending on the HPLC method, this impurity cannot be detected, which is critical for quality control.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.